{
  "title": "Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv",
  "url": "https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: Completing assessments reduced early discontinuation risk by 30%, from 33% to 22%."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Integrate automated day-3 reminders to boost assessment completion rates."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: Increasing adoption of PROs in clinical trials as regulatory pressure rises."
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Self-selection bias could limit generalizability of findings to sicker patient populations."
    }
  ],
  "model": "granite4:tiny-h"
}